Number of the records: 1  

Method of determination of cancer cell drug sensitivity towards aurora kinase inhibitors.

  1. 1.
    0531620 - ÚŽFG 2020 RIV eng P - Patent Document
    Kollaredy, M. R. N. - Hajdúch, M. - Dzubak, P. - Srovnal, J. - Hrabáková, Rita - Kovářová, Hana
    Method of determination of cancer cell drug sensitivity towards aurora kinase inhibitors.
    2016. Owner: Palacký University Olomouc, Institute of Animal Physiology and Genetics CAS. Date of the patent acceptance: 17.08.2016. Patent Number: EP2788504
    R&D Projects: GA MŠMT(CZ) LO1609
    Institutional support: RVO:67985904
    Keywords : aurora kinase inhibitors
    OECD category: Cell biology
    https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20160817&DB=&locale=en_EP&CC=EP&NR=2788504B1&KC=B1&ND=4#

    The invention relates to a method of determination of a cancer cell drug sensitivity (whether the cancer cell is sensitive or resistant) towards Aurora kinase inhibitors as well as to the compound which can be used for overcoming the resistence.
    Permanent Link: http://hdl.handle.net/11104/0310248

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.